Substance use and substance use disorder differ by the frequency of use and the effect on a person’s life. Substance use disorder is a mental health condition. Substance use refers to using both legal ...

Polysubstance use disorder is a mental health condition in which someone uses more than one substance at the same time or within a short period of time, despite a pattern of negative effects.

Nearly 19 million US children live with at least one parent meeting Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition; DSM-5) criteria for substance use disorder (SUD), representing ...

The co-occurrence of attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD) presents a complex challenge in psychiatric care. Individually ...

Fibromyalgia and chronic pain create a "fertile breeding ground" for self-medication and iatrogenic addiction. . Fibromyalgia involves abnormal pain processing; the brain struggles to turn off pain ...

Diagnosing substance-use disorder can be difficult because of patient denial related to the stigma attached to addiction. But a new study by the University of Cincinnati uses a novel artificial ...

Adults who smoke cigarettes and are addicted to alcohol or other drugs were more likely to achieve sustained remission of their substance use disorder symptoms if they also quit smoking, according to ...

The President’s FY 2026 budget proposes major changes in the federal discretionary budget for health care, which could have serious implications for behavioral health care; some changes are already ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new study has found that substance use disorders (SUD) cost the U.S.

The Substance Abuse and Mental Health Services Administration's 2024 Final Rule includes a comprehensive set of regulations distributed by the organization. These rules serve as guidelines and ...

Target-trial emulation in VA EHRs constructed eight parallel new-user trials comparing GLP-1 RA initiators with SGLT-2 inhibitor initiators under two protocols: incident SUDs and SUD-related adverse ...